Cell-Promoted Nanoparticle Aggregation Decreases Nanoparticle-Induced Hyperthermia under an Alternating Magnetic Field Independently of Nanoparticle Coating, Core Size, and Subcellular Localization
Source abstract
Abstract
Magnetic hyperthermia has a significant potential to be a new breakthrough for cancer treatment. The simple concept of nanoparticle-induced heating by the application of an alternating magnetic field has attracted much attention, as it allows the local heating of cancer cells, which are considered more susceptible to hyperthermia than healthy cells, while avoiding the side effects of traditional hyperthermia. Despite the potential of this therapeutic approach, the idea that local heating effects due to the application of alternating magnetic fields on magnetic nanoparticle-loaded cancer cells can be used as a treatment is controversial. Several studies indicate that the heating capacity of magnetic nanoparticles is largely reduced in the cellular environment because of increased viscosity, aggregation, and dipolar interactions. However, an increasing number of studies, both in vitro and in vivo, show evidence of successful magnetic hyperthermia treatment on several different types of cancer cells. This apparent contradiction might be due to the use of different experimental conditions. Here, we analyze the effects of several parameters on the cytotoxic efficiency of magnetic nanoparticles as heat inductors under an alternating magnetic field. Our results indicate that the cell-nanoparticle interaction reduces the cytotoxic effects of magnetic hyperthermia, independent of nanoparticle coating and core size, the cell line used, and the subcellular localization of nanoparticles. However, there seems to occur a synergistic effect between the application of an external source of heat and the presence of magnetic nanoparticles, leading to higher toxicities than those induced by heat alone or the accumulation of nanoparticles within cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Immunology and Oncology, and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB/CSIC), Darwin 3, Campus de Cantoblanco, 28049 Madrid, Spain
Department of Energy, Environment and Health, Instituto de Ciencia de Materiales de Madrid (ICMM/CSIC), Sor Juana Inés de la Cruz 3, Campus de Cantoblanco, 28049 Madrid, Spain
Funding
Ministerio de Econom?a y Competitividad · Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · European Cooperation in Science and Technology
References (83)
Show source-provided references
1. 10.1039/c2cs15337h10.1039/c2cs15337h ↗
2. 10.1016/j.bbrep.2017.12.00210.1016/j.bbrep.2017.12.002 ↗
3. 10.1016/j.biomaterials.2011.02.03110.1016/j.biomaterials.2011.02.031 ↗
4. 10.1016/j.jconrel.2013.07.01910.1016/j.jconrel.2013.07.019 ↗
5. 10.1016/j.actbio.2017.05.04710.1016/j.actbio.2017.05.047 ↗
6. 10.1021/acsnano.6b0287610.1021/acsnano.6b02876 ↗
7. 10.1002/btm2.1000310.1002/btm2.10003 ↗
8. 10.1080/0265673070176984110.1080/02656730701769841 ↗
9. 10.1186/s13014-015-0462-010.1186/s13014-015-0462-0 ↗
10. Skitzki J. · Curr. Opin. Investig. Drugs · 2009 · 10 · 550
11. 10.1615/critrevbiomedeng.v38.i1.8010.1615/critrevbiomedeng.v38.i1.80 ↗
12. 10.1093/annonc/mdf28010.1093/annonc/mdf280 ↗
13. 10.1016/j.biomaterials.2011.12.05210.1016/j.biomaterials.2011.12.052 ↗
14. 10.1016/s0304-8853(02)00706-010.1016/s0304-8853(02)00706-0 ↗
15. 10.3109/02656736.2013.83864610.3109/02656736.2013.838646 ↗
16. 10.2147/ott.s4281510.2147/ott.s42815 ↗
17. 10.1186/1471-2407-10-11910.1186/1471-2407-10-119 ↗
18. 10.1016/j.pnsc.2009.06.00610.1016/j.pnsc.2009.06.006 ↗
19. 10.1007/s11060-005-9059-z10.1007/s11060-005-9059-z ↗
20. 10.1007/s11095-014-1417-010.1007/s11095-014-1417-0 ↗
21. 10.1080/0265673060117547910.1080/02656730601175479 ↗
22. 10.1016/j.eururo.2006.11.02310.1016/j.eururo.2006.11.023 ↗
23. 10.1007/s11060-006-9195-010.1007/s11060-006-9195-0 ↗
24. 10.1080/0265673060110603710.1080/02656730601106037 ↗
25. 10.1007/s11060-010-0389-010.1007/s11060-010-0389-0 ↗
26. 10.1038/cddis.2013.12110.1038/cddis.2013.121 ↗
27. 10.1021/nn201822b10.1021/nn201822b ↗
28. 10.1088/0957-4484/22/20/20510110.1088/0957-4484/22/20/205101 ↗
29. 10.2147/ijn.s1461310.2147/ijn.s14613 ↗
30. 10.1021/jp907046f10.1021/jp907046f ↗
31. 10.1021/nn400704810.1021/nn4007048 ↗
32. 10.1016/j.jconrel.2017.11.05010.1016/j.jconrel.2017.11.050 ↗
33. 10.1002/smll.20140266910.1002/smll.201402669 ↗
34. 10.1038/srep3356010.1038/srep33560 ↗
35. 10.1021/jp310139210.1021/jp3101392 ↗
36. 10.1180/claymin.2012.047.3.0110.1180/claymin.2012.047.3.01 ↗
37. 10.1039/c4ra13564d10.1039/c4ra13564d ↗
38. 10.1016/j.actbio.2015.06.03710.1016/j.actbio.2015.06.037 ↗
39. 10.1142/s233954781450019810.1142/s2339547814500198 ↗
40. 10.1016/j.biomaterials.2014.04.03610.1016/j.biomaterials.2014.04.036 ↗
41. 10.1021/nn503888j10.1021/nn503888j ↗
42. 10.1038/srep3992210.1038/srep39922 ↗
43. 10.1021/acsnano.7b0899510.1021/acsnano.7b08995 ↗
44. 10.1039/c8cp03016b10.1039/c8cp03016b ↗
45. 10.1038/s41598-018-19628-z10.1038/s41598-018-19628-z ↗
46. 10.1038/srep0502010.1038/srep05020 ↗
47. 10.1016/j.jmmm.2011.05.01810.1016/j.jmmm.2011.05.018 ↗
48. 10.1021/jp310771p10.1021/jp310771p ↗
49. 10.2147/ijn.s3611110.2147/ijn.s36111 ↗
50. 10.1016/j.biomaterials.2011.08.04810.1016/j.biomaterials.2011.08.048 ↗
51. 10.1016/j.biomaterials.2014.04.00910.1016/j.biomaterials.2014.04.009 ↗
52. 10.1007/s11051-015-2921-910.1007/s11051-015-2921-9 ↗
53. 10.1002/cyto.a.2249510.1002/cyto.a.22495 ↗
54. 10.1002/jgm.69610.1002/jgm.696 ↗
55. 10.1002/cyto.a.2092710.1002/cyto.a.20927 ↗
56. 10.1021/ar600012y10.1021/ar600012y ↗
57. 10.1007/s11095-012-0710-z10.1007/s11095-012-0710-z ↗
58. 10.1021/mp400015b10.1021/mp400015b ↗
59. 10.1128/mcb.17.9.531710.1128/mcb.17.9.5317 ↗
60. 10.1038/nri74910.1038/nri749 ↗
61. 10.4236/ojapps.2017.71204710.4236/ojapps.2017.712047 ↗
62. 10.1063/1.353002710.1063/1.3530027 ↗
63. 10.1016/j.biomaterials.2005.12.02210.1016/j.biomaterials.2005.12.022 ↗
64. 10.1016/j.colsurfb.2012.02.02210.1016/j.colsurfb.2012.02.022 ↗
65. 10.2147/ijn.s11046510.2147/ijn.s110465 ↗
66. 10.1038/nmat259110.1038/nmat2591 ↗
67. 10.1021/acsnano.7b0176210.1021/acsnano.7b01762 ↗
68. 10.2147/ijn.s14107210.2147/ijn.s141072 ↗
69. 10.1021/nn204813710.1021/nn2048137 ↗
70. 10.2217/nnm.15.18510.2217/nnm.15.185 ↗
71. 10.1007/s40843-017-9088-910.1007/s40843-017-9088-9 ↗
72. Huang P. · Semin. Oncol. · 1995 · 22 · 19
73. 10.1016/j.biomaterials.2016.11.00810.1016/j.biomaterials.2016.11.008 ↗
74. 10.1117/12.80981810.1117/12.809818 ↗
75. 10.1021/acs.analchem.5b0012410.1021/acs.analchem.5b00124 ↗
76. 10.1039/c1jm11916h10.1039/c1jm11916h ↗
77. 10.3390/nano812097010.3390/nano8120970 ↗
78. 10.1021/acsami.8b0283010.1021/acsami.8b02830 ↗
79. 10.1021/am509161y10.1021/am509161y ↗
80. 10.1039/c3nr02148c10.1039/c3nr02148c ↗
81. Barber, D. F.; Mejías, R.; Tajada-Herráiz, J. L.; Pérez-Yagüe, S.; Talelli, M. Device for Generating Hyperthermia in Cells by Means of Magnetic Nanoparticles (MNPs), Method for Determining Temperature in Cells Using Said Device, and Use of the Device to Determine the Temperature in Cells. WO2016059283, April 21, 2016.
82. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
83. 10.1002/smll.20130384110.1002/smll.201303841 ↗